Immune Checkpoint-Blocking Nanocages Cross the Blood–Brain Barrier and Impede Brain Tumor Growth-Reference-Cited by-同舟云学术

Immune Checkpoint-Blocking Nanocages Cross the Blood–Brain Barrier and Impede Brain Tumor Growth

Published:2023-12-27 Issue:1 Volume:10 Page:575-587
ISSN:2373-9878
Container-title:ACS Biomaterials Science & Engineering
language:en
Short-container-title:ACS Biomater. Sci. Eng.

Author:

Kim Minseong¹²³,Yoon Hee Jung⁴,Lee Chanju⁴,Lee Minah¹²³,Park Rang-Woon¹²³^ORCID,Lee Byungheon¹²³^ORCID,Park Eun Jung⁴^ORCID,Kim Soyoun¹²³^ORCID

Affiliation:

1. Department of Biochemistry and Cell Biology, School of Medicine, Kyungpook National University, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, Republic of Korea

2. BK21 Plus KNU Biomedical Convergence Program, Department of Biomedical Science, School of Medicine, Kyungpook National University, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, Republic of Korea

3. CMRI, School of Medicine, Kyungpook National University, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, Republic of Korea

4. Immuno-Oncology Branch, Division of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang 10408, Republic of Korea

Funder

National Cancer Center

National Research Foundation of Korea

Publisher

American Chemical Society (ACS)

Subject

Biomedical Engineering,Biomaterials

Link

https://pubs.acs.org/doi/pdf/10.1021/acsbiomaterials.3c01200

Reference60 articles.

1. Elements of cancer immunity and the cancer–immune set point

2. Cancer immunotherapy: harnessing the immune system to battle cancer

3. Fundamental Mechanisms of Immune Checkpoint Blockade Therapy

4. PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer

5. Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma